Fig. 3From: Crohn’s disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemicUC- (a) and CD- (b) bowel signs and symptoms and abdominal signs evaluated before (T0) and after (T1) therapy escalation. Statistical significance (p value) of differences between the two time points is indicated in the plots. (ns) not significantBack to article page